Anika Therapeutics Inc. (ANIK) vs Lifecore Biomedical, Inc. (LFCR)
- Anika Therapeutics Inc. ANIK 19.31 −5.34%
- Lifecore Biomedical, Inc. LFCR 6.39 −0.78%
Anika Therapeutics Inc. and Lifecore Biomedical, Inc. are both Drug Manufacturers Specialty & Generic companies. Anika Therapeutics Inc. and Lifecore Biomedical, Inc. are of similar size ($258.7M and $242.6M). Anika Therapeutics Inc. grew revenue faster over the last twelve months: 5.33% against −18.2%. Anika Therapeutics Inc. has the higher net margin (−3.14% vs −65.9%) and the lower return on invested capital (−3.24% vs 0.00%). Across the 17 metrics below, Anika Therapeutics Inc. leads on 10 and Lifecore Biomedical, Inc. on 7.
Valuation
Profitability
| Metric | ANIK | LFCR | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 62.16% | 27.38% | 53.51% |
| Operating margin | (4.24%) | (5.33%) | 0.00% |
| Net margin | (3.14%) | (65.91%) | (2.45%) |
| Free cash flow margin | 0.47% | 9.86% | 0.00% |
| Return on equity | (2.66%) | 178.69% | (0.80%) |
| Return on assets | (2.04%) | (32.36%) | (1.67%) |
| Return on invested capital | (3.24%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack